Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company’s quarterly dividend to $0.46 per outstanding share of the company’s common stock, up $0.01 from $0.45 per outstanding share paid last quarter. Payment will be made on Jan. 8, 2016, to stockholders of record at the close of business on Dec. 15, 2015.
“We continue to make scientific progress in some of the world’s most challenging areas of unmet medical need,” said Kenneth C. Frazier, chairman and chief executive officer, Merck. “The increase in our dividend reflects confidence in our future and our ongoing commitment to creating valu e for shareholders.”
Merck last announced a dividend increase in November 2014, when the Board raised the dividend from $0.44 to $0.45 per common share.
